Delivery Order SPE2DB22D9207-SPE2DB25FH5CP
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,477.76 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical treatment. This delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,659.20 by the Defense Logistics Agency (DLA) on July 22, 2025. The delivery order, which is set to be completed by August 12, 2025, calls for the supply of 500 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used in medical and emergency care settings. The award was issued without a set-aside...
- The Defense Logistics Agency issued a delivery order valued at $27,961.92 to DMS Pharmaceutical Group Inc. for the supply of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used for emergency reversal of anticoagulation. The award, effective August 25, 2025 with completion targeted for September 16, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,213.76 by the Defense Logistics Agency on August 26, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a prothrombin complex concentrate used to reverse warfarin anticoagulation. The delivery order carries an ultimate completion date of September 17, 2025, and was awarded without a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $39,520 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for rapid reversal of warfarin anticoagulation. This firm fixed-price delivery order, issued on August 12, 2025, with ultimate completion by September 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November...
- The Defense Logistics Agency awarded a $27,961.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 19, 2025, for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor complex used for treating bleeding associated with warfarin or novel anticoagulant overdose. This delivery order, with an ultimate completion date of September 10, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $93,282.40 by the Defense Logistics Agency (DLA) on August 28, 2025. The contract calls for the delivery of 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used in medical settings. The delivery order carries an ultimate completion date of September 19, 2025, and was issued without a set-aside...
- The Defense Logistics Agency awarded a $7,296.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 unit vials of Kcentra. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,546.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 500-unit vials of Kcentra. The delivery order, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, employs firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,641.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5CPDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 25, 2025, by the Defense Logistics Agency (DLA) for 1,000 unit vials of Kcentra, a vitamin K-dependent clotting factor concentrate used to reverse anticoagulation. The firm fixed-price delivery order has a ceiling value of $19,845.12 with an ultimate completion date of August 15, 2025. This award was issued without a set-aside designation, enabling the company to compete directly in the federal marketplace based on its woman-owned small business status. This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and specialty pharmaceutical products distributed to military health facilities. The Park Ridge, Illinois location serves as the place of performance for this delivery order supporting DLA's medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 7/25/25 |